Emergent BioSolutions Files 8-K
Ticker: EBS · Form: 8-K · Filed: May 23, 2025 · CIK: 1367644
| Field | Detail |
|---|---|
| Company | Emergent Biosolutions Inc. (EBS) |
| Form Type | 8-K |
| Filed Date | May 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Emergent BioSolutions filed an 8-K on 5/23/25. Details TBD.
AI Summary
Emergent BioSolutions Inc. filed an 8-K on May 23, 2025, reporting other events and financial statements. The filing does not contain specific details about the nature of these events or any financial figures within the provided text.
Why It Matters
This filing indicates that Emergent BioSolutions has made a regulatory submission to the SEC, which could contain important updates about the company's operations or financial status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting events, and the provided text does not contain any specific negative or positive material information.
Key Players & Entities
- Emergent BioSolutions Inc. (company) — Registrant
- May 23, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-33137 (identifier) — Commission File Number
- 14-1902018 (identifier) — IRS Employer Identification No.
- 300 Professional Drive, Gaithersburg, Maryland 20879 (address) — Address of principal executive offices
FAQ
What specific events are being reported in this 8-K filing?
The provided text indicates the filing is for 'Other Events' and 'Financial Statements and Exhibits' but does not detail the specific nature of these events.
When was this 8-K report filed?
The report was filed on May 23, 2025.
What is the principal executive office address for Emergent BioSolutions Inc.?
The address is 300 Professional Drive, Gaithersburg, Maryland 20879.
What is the Commission File Number for Emergent BioSolutions Inc.?
The Commission File Number is 001-33137.
What is the IRS Employer Identification Number for Emergent BioSolutions Inc.?
The IRS Employer Identification Number is 14-1902018.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 regarding Emergent BioSolutions Inc. (EBS).